Literature DB >> 24068770

Ductal carcinoma in situ: a rose by any other name.

D Lawrence Wickerham1, Thomas B Julian.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24068770      PMCID: PMC3797027          DOI: 10.1093/jnci/djt268

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  16 in total

1.  Gene expression profiles of human breast cancer progression.

Authors:  Xiao-Jun Ma; Ranelle Salunga; J Todd Tuggle; Justin Gaudet; Edward Enright; Philip McQuary; Terry Payette; Maria Pistone; Kimberly Stecker; Brian M Zhang; Yi-Xiong Zhou; Heike Varnholt; Barbara Smith; Michelle Gadd; Erica Chatfield; Jessica Kessler; Thomas M Baer; Mark G Erlander; Dennis C Sgroi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-24       Impact factor: 11.205

2.  Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.

Authors:  P O'Connell; V Pekkel; S A Fuqua; C K Osborne; G M Clark; D C Allred
Journal:  J Natl Cancer Inst       Date:  1998-05-06       Impact factor: 13.506

3.  Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

Authors:  B Fisher; J Dignam; N Wolmark; D L Wickerham; E R Fisher; E Mamounas; R Smith; M Begovic; N V Dimitrov; R G Margolese; C G Kardinal; M T Kavanah; L Fehrenbacher; R H Oishi
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

4.  Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?

Authors:  Rinaa S Punglia; Stuart J Schnitt; Jane C Weeks
Journal:  J Natl Cancer Inst       Date:  2013-09-25       Impact factor: 13.506

5.  Prospective study of wide excision alone for ductal carcinoma in situ of the breast.

Authors:  Julia S Wong; Carolyn M Kaelin; Susan L Troyan; Michele A Gadd; Rebecca Gelman; Susan C Lester; Stuart J Schnitt; Dennis C Sgroi; Barbara J Silver; Jay R Harris; Barbara L Smith
Journal:  J Clin Oncol       Date:  2006-02-06       Impact factor: 44.544

6.  Trends in the treatment of ductal carcinoma in situ of the breast.

Authors:  Nancy N Baxter; Beth A Virnig; Sara B Durham; Todd M Tuttle
Journal:  J Natl Cancer Inst       Date:  2004-03-17       Impact factor: 13.506

7.  Molecular markers in ductal carcinoma in situ of the breast.

Authors:  Dale Porter; Jaana Lahti-Domenici; Aparna Keshaviah; Young Kyung Bae; Pedram Argani; Jeffrey Marks; Andrea Richardson; Amiel Cooper; Robert Strausberg; Gregory J Riggins; Stuart Schnitt; Edward Gabrielson; Rebecca Gelman; Kornelia Polyak
Journal:  Mol Cancer Res       Date:  2003-03       Impact factor: 5.852

Review 8.  Do myoepithelial cells hold the key for breast tumor progression?

Authors:  Kornelia Polyak; Min Hu
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-07       Impact factor: 2.698

9.  Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.

Authors:  F Wärnberg; H Nordgren; L Bergkvist; L Holmberg
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

10.  The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin.

Authors:  Stuart J Schnitt
Journal:  Breast Cancer Res       Date:  2009-02-27       Impact factor: 6.466

View more
  5 in total

1.  A comparison of the risks of in-breast recurrence after a diagnosis of dcis or early invasive breast cancer.

Authors:  S A Narod; E Rakovitch
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

2.  DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.

Authors:  Kevin C Johnson; Devin C Koestler; Thomas Fleischer; Panpan Chen; Erik G Jenson; Jonathan D Marotti; Tracy Onega; Vessela N Kristensen; Brock C Christensen
Journal:  Clin Epigenetics       Date:  2015-07-25       Impact factor: 6.551

3.  Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.

Authors:  Michèl Schummer; Jason Thorpe; Maria D Giraldez; Maria Giraldez; Lindsay Bergan; Muneesh Tewari; Nicole Urban
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

4.  The gene regulatory network for breast cancer: integrated regulatory landscape of cancer hallmarks.

Authors:  Frank Emmert-Streib; Ricardo de Matos Simoes; Paul Mullan; Benjamin Haibe-Kains; Matthias Dehmer
Journal:  Front Genet       Date:  2014-02-03       Impact factor: 4.599

Review 5.  Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer.

Authors:  Rebecca S DeVaux; Jason I Herschkowitz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-10-10       Impact factor: 2.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.